CART-cell therapy for SLE in children

被引：0
|
作者：
Burki, Talha
机构：
来源：
LANCET RHEUMATOLOGY | 2024年 / 6卷 / 06期
关键词：
D O I：
10.1016/S2665-9913(24)00098-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e338 / e338
页数：1
相关论文
共 50 条
  • [1] Regulatory hurdles for CART-cell therapy in Japan
    Nagai, Sumimasa
    LANCET HAEMATOLOGY, 2021, 8 (10): : E686 - E687
  • [2] Combinational CART-cell therapy for solid tumors: Requisites, rationales, and trials
    Misawa, Kyohei
    Bhat, Hina
    Adusumilli, Prasad S.
    Hou, Zhaohua
    PHARMACOLOGY & THERAPEUTICS, 2025, 266
  • [3] CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
    Martino, Massimo
    Canale, Filippo Antonio
    Alati, Caterina
    Vincelli, Iolanda Donatella
    Moscato, Tiziana
    Porto, Gaetana
    Loteta, Barbara
    Naso, Virginia
    Mazza, Massimiliano
    Nicolini, Fabio
    Ghelli Luserna di Rora, Andrea
    Simonetti, Giorgia
    Ronconi, Sonia
    Ceccolini, Michela
    Musuraca, Gerardo
    Martinelli, Giovanni
    Cerchione, Claudio
    CANCERS, 2021, 13 (11)
  • [4] Medicare to Cover CART-Cell Therapies
    Rubin, Rita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (12): : 1133 - 1133
  • [5] Making CART-cell therapies more affordable
    Senior, Kathryn
    LANCET, 2025, 405 (10474): : 187 - 188
  • [6] THERAPY IN MALIGNANT HEMOPATHY WITH CART-CELL: EXPERIENCE IN THE AUTONOMOUS COMMUNITY OF ARAGON
    Moreno Carbonell, M.
    Olave Rubio, M. T.
    Paul Vidaller, P.
    Carrasco Baraja, V
    Gonzalez Gomez, E.
    Gomez Martinez, A.
    Hernandez Mata, C. F.
    Martin-Consuegra, S.
    Civeira Marin, M.
    Lopez Pena, A.
    Rodriguez Lefler, C.
    Herrero Gutierrez, M. M.
    Lopez Gomez, P. E.
    Ordas Miguelez, M. S.
    Delgado Beltran, P.
    Izquierdo Garcia, I.
    HAEMATOLOGICA, 2021, 106 (10) : 368 - 368
  • [7] CART-Cell Therapies in Glioblastoma: A First Look
    Migliorini, Denis
    Dietrich, Pierre-Yves
    Stupp, Roger
    Linette, Gerald P.
    Posey, Avery D., Jr.
    June, Carl H.
    CLINICAL CANCER RESEARCH, 2018, 24 (03) : 535 - 540
  • [8] CRISPR Takes the Front Seat in CART-Cell Development
    Manriquez-Roman, Claudia
    Siegler, Elizabeth L.
    Kenderian, Saad S.
    BIODRUGS, 2021, 35 (02) : 113 - 124
  • [9] Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CART-cell Therapy
    McNerney, Kevin O.
    DiNofia, Amanda M.
    Teachey, David T.
    Grupp, Stephan A.
    Maude, Shannon L.
    BLOOD CANCER DISCOVERY, 2022, 3 (02): : 90 - 94
  • [10] CD22-directed CART-cell therapy for large B-cell lymphomas progressing after CD19-directed CART-cell therapy: a dose- finding phase 1 study
    Frank, Matthew J.
    Baird, John H.
    Kramer, Anne Marijn
    Srinagesh, Hrishikesh K.
    Patel, Shabnum
    Brown, Annie Kathleen
    Oak, Jean S.
    Younes, Sheren F.
    Natkunam, Yasodha
    Hamilton, Mark P.
    Su, Yi-Jiun
    Agarwal, Neha
    Chinnasamy, Harshini
    Egeler, Emily
    Mavroukakis, Sharon
    Feldman, Steven A.
    Sahaf, Bita
    Mackall, Crystal L.
    Muffly, Lori
    Miklos, David B.
    LANCET, 2024, 404 (10450): : 353 - 363
12345